|
1）Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124: 783-801
|
|
|
|
2）Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006; 117: 979-87
|
|
|
|
|
|
3）Kawai T, Akira S. TLR signaling. Semin Immunol. 2007; 19: 24-32
|
|
|
|
|
|
4）Takeuchi O, Akira S. Signaling pathways activated by microorganisms. Curr Opin Cell Biol. 2007; 19: 185-91
|
|
|
|
|
|
5）Uematsu S, Akira S. Toll-like receptors and Type I interferons. J Biol Chem. 2007; 282: 15319-23
|
|
|
|
|
|
6）Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol. 2004; 4: 249-58
|
|
|
|
|
|
7）Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004; 5: 1219-26
|
|
|
|
|
|
8）Hemmi H, Kaisho T, Takeda K, et al. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol. 2003; 170: 3059-64
|
|
|
|
|
|
9）Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006; 25: 349-60
|
|
|
|
|
|
10）Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6: 644-58
|
|
|
|
|
|
11）Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005; 434: 772-7
|
|
|
|
|
|
12）Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004; 25: 280-8
|
|
|
|
|
|
13）Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004; 18: 2195-224
|
|
|
|
|
|
14）Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem. 1999; 274: 27339-42
|
|
|
|
|
|
15）McWhirter SM, Fitzgerald KA, Rosains J, et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci USA. 2004; 101: 233-8
|
|
|
|
|
|
16）Kato H, Sato S, Yoneyama M, et, al. Cell type-specific involvement of RIG-I in antiviral response. Immunity. 2005; 23: 19-28
|
|
|
|
|
|
17）Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006; 441: 101-5
|
|
|
|
|
|
18）Hemmi H, Takeuchi O, Sato S, et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med. 2004; 199: 1641-50
|
|
|
|
|
|
19）Perry AK, Chow EK, Goodnough JB, et al. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med. 2004; 199: 1651-8
|
|
|
|
|
|
20）Hoshino K, Sugiyama T, Matsumoto M, et al. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature. 2006; 440: 949-53
|
|
|
|
|
|
21）Honda K, Yanai H, Mizutani T, et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA. 2004; 101: 15416-21
|
|
|
|
|
|
22）Kawai T, Sato S, Ishii KJ, et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol. 2004; 5: 1061-8
|
|
|
|
|
|
23）Uematsu S, Sato S, Yamamoto M, et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med. 2005; 201: 915-23
|
|
|
|
|
|
24）Kawagoe T, Sato S, Jung A, et al. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J Exp Med. 2007; 204: 1013-24
|
|
|
|
|
|
25）Kim TW, Staschke K, Bulek K, et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med. 2007; 204: 1025-36
|
|
|
|
|
|
26）Yang K, Puel A, Zhang S, et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity. 2005; 23: 465-78
|
|
|
|
|
|
27）Shinohara ML, Lu L, Bu J, et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol. 2006; 7: 498-506
|
|
|
|
|
|
28）Hacker H, Redecke V, Blagoev B, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006; 439: 204-7
|
|
|
|
|
|
29）Oganesyan G, Saha SK, Guo B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature. 2006; 439: 208-11
|
|
|
|
|
|
30）Hoshino K, Kaisho T, Iwabe T, et al. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int Immunol. 2002; 14: 1225-31
|
|
|
|
|
|
31）Negishi H, Fujita Y, Yanai H, et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci USA. 2006; 103: 15136-41
|
|
|
|
|
|
32）Schmitz F, Heit A, Guggemoos S, et al. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol. 2007; 37: 315-27
|
|
|
|
|
|
33）Ishii KJ, Coban C, Kato H, et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol. 2006; 7: 40-8
|
|
|
|
|
|
34）Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007; 448: 501-5
|
|
|
|
|
|
35）Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol. 2006; 18: 676-82
|
|
|
|
|
|
36）Means TK, Latz E, Hayashi F, et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005; 115: 407-17
|
|
|
|
|